NCT00131144View on ClinicalTrials.gov

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

PHASE3CompletedINTERVENTIONAL
Enrollment

583

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Diabetic Retinopathy
Interventions
DRUG

Octreotide Acetate in Microspheres 20 mg

DRUG

Octreotide Acetate in Microspheres

DRUG

Placebo

Trial Locations (1)

07936

Novartis, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00131144 - Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy | Biotech Hunter | Biotech Hunter